A comprehensive study of TP53 mutations in chronic lymphocytic leukemia: Analysis of 1287 diagnostic and 1148 follow-up CLL samples

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

Jamil Momand, Gerard P. Zambetti, David C. Olson et al. · Cell · 1992 · 3.1K citations

Oncogenic Agent, Medicine, Molecular Biology +9

More powerful procedures for multiple significance testing

Yosef Hochberg, Yoav Benjamini · Statistics in Medicine · 1990 · 2.7K citations

Neuropsychology, Comparative Test, Psychopharmacology +22

Understanding the function–structure and function–mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis

Shunsuke Kato, Shuang-Yin Han, Wen Liu et al. · Proceedings of the National Academy of Sciences · 2003 · 869 citations · Full text

Engineering, Molecular Biology, Function–mutation Relationships +17

p53 isoforms can regulate p53 transcriptional activity

Jean‐Christophe Bourdon, Kenneth Fernandes, F Murray-Zmijewski et al. · Genes & Development · 2005 · 792 citations · Full text

Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage

Jitka Malčíková, Jana Šmardová, Ludmila Ročňová et al. · Blood · 2009 · 184 citations · Full text